J&J depression drug Spravato gets half-hearted backing from VA doctors despite Trump's zeal

J&J depression drug Spravato gets half-hearted backing from VA doctors despite Trump's zeal

Source: 
Fierce Pharma
snippet: 

Despite unconventional support from President Donald Trump, Johnson & Johnson’s Spravato didn’t win broad backing at the U.S. Department of Veteran’s Affairs. Agency clinicians instead approved the depression spray’s use on a limited basis, requiring patients to try other options first.